Supplemental material
Research Paper
Stabilization of negative activation voltages of Cav1.3 L-Type Ca2+-channels by alternative splicing
Nadja T. Hofera Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Austria
https://orcid.org/0000-0002-2812-2945
https://orcid.org/0000-0002-2812-2945, Alexandra Pinggerab Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, UKhttps://orcid.org/0000-0001-7120-6194
https://orcid.org/0000-0001-7120-6194, Yuliia V. Nikonishynaa Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Austriahttps://orcid.org/0000-0002-9435-3610
https://orcid.org/0000-0002-9435-3610, Petronel Tuluca Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Austriahttps://orcid.org/0000-0003-3660-6138
https://orcid.org/0000-0003-3660-6138, Eva M. Fritza Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, Austriahttps://orcid.org/0000-0003-2936-2622
https://orcid.org/0000-0003-2936-2622, Gerald J. Obermairc Institute of Physiology, Medical University Innsbruck, Innsbruck, Austria;d Division Physiology, Karl Landsteiner University of Health Sciences, Krems, Austriahttps://orcid.org/0000-0003-0005-8563
https://orcid.org/0000-0003-0005-8563 & Jörg Striessniga Department of Pharmacology and Toxicology, Centre for Molecular Biosciences, University of Innsbruck, AustriaCorrespondence[email protected]
https://orcid.org/0000-0002-9406-7120
https://orcid.org/0000-0002-9406-7120 show allRelated Research Data
Stabilization of negative activation voltages of Cav1.3 L-Type Ca2+-channels by alternative splicing
Source:
Taylor & Francis
Linking provided by
